ACToR-study : Angiographic CT of Renal Transplantation Candidate - Study (ACToR)
Renal Transplant Candidate for Right Kidney
Renal Transplant Candidate for Left Kidney
|Study Design:||Time Perspective: Retrospective|
|Official Title:||Angiographic CT of Renal Transplantation Candidate - Study|
- To investigate the ability of non-invasive tests to detect CAD as defined by invasive angiography in renal transplantation candidates. [ Time Frame: 2013 october ] [ Designated as safety issue: No ]Baseline results of coronary computed tomographic angiography (cCTA), myocardial perfusion scintigraphy (MPS), acoustic CAD Patch and combination hereof to detect CAD as defined by invasive Coronary angiography (CAG).
- To investigate the risk of Contrast-Induced Nephropathy (CIN) after cCTA and CAG. [ Time Frame: 2013 october ] [ Designated as safety issue: Yes ]Blood sample of creatinine after contrast exposure.
|Study Start Date:||February 2011|
|Study Completion Date:||February 2014|
|Primary Completion Date:||February 2014 (Final data collection date for primary outcome measure)|
Chronic kidney disease is a known risk factor for cardiovascular disease and cardiovascular disease is the leading cause of mortality in end-stage renal disease (ESRD) patients. After renal transplantation one-half of all deaths are cardiac, usually in the first 5 years in the presence of a functional graft. Because of this renal transplantation candidates are undergoing cardiac pre-transplant risk stratification.
There is no consensus regarding which modality should be use for detection of CAD in this cardiac pre-transplant risk stratification. CAG is known as gold standard but is a invasive procedure with risk of complication.
The investigators wish to investigate the ability of detecting CAD as defined by invasive Coronary angiography (CAG) by clinical examination, blood test and non-invasive test (cCTA, MPS and acoustic CAD Patch). The investigators hypothesize that a single modality or combination of these with high sensitivity and specificity could diagnose significant CAD without the need of further invasive procedures.
This study will include 150 renal transplantations candidate.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01344434
|Aarhus, Denmark, 8200|
|Principal Investigator:||Simon Winther, MD||Department of Cardiology, Skejby Sygehus, Denmark|